Cargando…
Retraction Note: HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395
Autores principales: | Sun, Guoliang, Zhou, Hui, Chen, Ke, Zeng, Jin, Zhang, Yangjun, Yan, Libin, Yao, Weimin, Hu, Junhui, Wang, Tao, Xing, Jinchun, Xiao, Kefeng, Wu, Lily, Ye, Zhangqun, Xu, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906818/ https://www.ncbi.nlm.nih.gov/pubmed/36755337 http://dx.doi.org/10.1186/s13046-023-02613-4 |
Ejemplares similares
-
HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395
por: Sun, Guoliang, et al.
Publicado: (2020) -
Paralogs hnRNP L and hnRNP LL Exhibit Overlapping but Distinct RNA Binding Constraints
por: Smith, Sarah A., et al.
Publicado: (2013) -
hnRNP A1 and hnRNP F Modulate the Alternative Splicing of Exon 11 of the Insulin Receptor Gene
por: Talukdar, Indrani, et al.
Publicado: (2011) -
HnRNP L represses cryptic exons
por: McClory, Sean P., et al.
Publicado: (2018) -
HnRNP Pathologies in Frontotemporal Lobar Degeneration
por: Jiang, Xinwa, et al.
Publicado: (2023)